Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults-Reference-Cited by-同舟云学术

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults

Published:2018-03 Issue: Volume:29 Page:146-154
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Coughlan L.,Sridhar S.,Payne R.,Edmans M.,Milicic A.,Venkatraman N.,Lugonja B.,Clifton L.,Qi C.,Folegatti P.M.,Lawrie A.M.,Roberts R.,de Graaf H.,Sukhtankar P.,Faust S.N.,Lewis D.J.M.,Lambe T.,Hill AVS,Gilbert S.C.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference20 articles.

1. A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50years;Antrobus;PLoS One,2012

2. Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses;Antrobus;Mol. Ther.,2014

3. Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens;Antrobus;Mol. Ther.,2014

4. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1;Berthoud;Clin. Infect. Dis.,2011

5. Immunosenescence: influenza vaccination and the elderly;Haq;Curr. Opin. Immunol.,2014

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study;The Lancet Microbe;2024-07

3. Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B;Journal of Hepatology;2024-07

4. A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein;eBioMedicine;2024-06

5. Development of a new vaccine at the laboratory scale;Bioreactor Design Concepts for Viral Vaccine Production;2024